Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Sandoz Expects ‘Trough Year’ In 2023 As It Counts Cost Of Spinoff
Novartis Management Outlines Path Ahead For Sandoz As It Prepares To Separate
Sandoz expects a trough for operating income in 2023, followed by growth • Source: Shutterstock
More from Earnings
More from Business